EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

What is autoimmune encephalitis‐associated epilepsy? Proposal of a practical definition

Anna Rada iD, Christian G Bien iD

Epilepsia · 2023-09 · 64 (9) · 2249-2255

DOI: 10.1111/epi.17699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 25.07.2023. Verfasst von Anna Rada und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epileptology (Krankenhaus Mara), Medical School, Bielefeld University, Bielefeld, Germany. Hauptthemen laut MEDLINE: Encephalitis, Epilepsy, Hashimoto Disease, Autoimmune Diseases of the Nervous System. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seizures resulting from cerebral autoimmunity are either acutely symptomatic in the context of autoimmune encephalitis (AIE) with neural surface antibodies, or they are indicative of an enduring predisposition to seizures, that is, epilepsy. Here, we propose a practical definition for autoimmune encephalitis‐associated epilepsy (AEAE): Seizures associated with antibodies against glutamic acid decarboxylase, paraneoplastic syndromes, or Rasmussen encephalitis are classified as AEAE. AEAE secondary to AIE with antibodies against the N ‐methyl‐D‐aspartate receptor, leucine‐rich glioma inactivated protein 1, contactin‐associated protein‐2, or γ‐aminobutyric acid‐B receptor can be diagnosed if the following criteria are met: seizures persist for at least 2 years after immunotherapy initiation; no signs of encephalitis on magnetic resonance imaging and no fluorodeoxyglucose positron emission tomography hypermetabolism; normal cerebrospinal fluid cell count; and a substantial decrease in antibody titers. This classification corresponds to different disease mechanisms. While AIE results from the pathogenic effects of neural antibodies, AEAE is probably the consequence of encephalitis‐related tissue damage and thereby mainly structurally mediated. The distinction between AIE and AEAE also has practical consequences: In AIE, immunotherapy is usually highly beneficial, whereas anti‐seizure medication has little effect. In AEAE, immunotherapy is less promising and the usual anti‐seizure interventions are preferable. In addition, the diagnosis of AEAE has social consequences in terms of driving and professional limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EncephalitisEpilepsyHashimoto DiseaseAutoimmune Diseases of the Nervous SystemHumansAutoantibodies

Stichwörter der Autor:innen

acute symptomatic seizuresautoimmune encephalitisautoimmune encephalitis-associated epilepsyclassification

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Department of Epileptology (Krankenhaus Mara), Medical School, Bielefeld University, Bielefeld, Germany.

ORCID-Profile: Anna Rada, Christian G Bien

Zitieren

APA

Rada, A., & Bien, C. G. (2023). What is autoimmune encephalitis‐associated epilepsy? Proposal of a practical definition. Epilepsia, 64(9), 2249-2255. https://doi.org/10.1111/epi.17699

Vancouver

Rada A, Bien CG. What is autoimmune encephalitis‐associated epilepsy? Proposal of a practical definition. Epilepsia. 2023;64(9):2249-2255. doi:10.1111/epi.17699

BibTeX
@article{Rada2023,
  author = {Rada, Anna and Bien, Christian G},
  title = {What is autoimmune encephalitis‐associated epilepsy? Proposal of a practical definition},
  journal = {Epilepsia},
  year = {2023},
  volume = {64},
  number = {9},
  pages = {2249--2255},
  doi = {10.1111/epi.17699}
}
Kostenlos starten →